Cite Filings / VIR / 0001950047-24-008105
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Vir Biotechnology, Inc. · Filed 2024-11-05 · Acc 0001950047-24-008105

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-11-07 4 EVP and General Counsel sold 4,397 shares at $10.11 ($44,454)
  • 2024-11-06 144 Sale of Securities
  • 2024-11-05 144 Sale of Securities
  • 2024-11-05 4 EVP and General Counsel sold 3,750 shares at an average $8.62 ($32,332)
  • 2024-11-04 10-Q Quarterly Report
  • 2024-10-31 8-K Results of operations
  • 2024-09-09 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…